JP2023011759A5 - - Google Patents

Download PDF

Info

Publication number
JP2023011759A5
JP2023011759A5 JP2022172687A JP2022172687A JP2023011759A5 JP 2023011759 A5 JP2023011759 A5 JP 2023011759A5 JP 2022172687 A JP2022172687 A JP 2022172687A JP 2022172687 A JP2022172687 A JP 2022172687A JP 2023011759 A5 JP2023011759 A5 JP 2023011759A5
Authority
JP
Japan
Prior art keywords
invention described
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP2022172687A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023011759A (ja
Filing date
Publication date
Priority claimed from JP2022538564A external-priority patent/JPWO2022018875A1/ja
Application filed filed Critical
Publication of JP2023011759A publication Critical patent/JP2023011759A/ja
Publication of JP2023011759A5 publication Critical patent/JP2023011759A5/ja
Priority to JP2026044825A priority Critical patent/JP2026102816A/ja
Ceased legal-status Critical Current

Links

JP2022172687A 2020-07-22 2022-10-27 アリールアミド誘導体を含む細胞増殖性疾患の治療又は予防用医薬組成物 Ceased JP2023011759A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2026044825A JP2026102816A (ja) 2020-07-22 2026-03-18 アリールアミド誘導体を含む細胞増殖性疾患の治療又は予防用医薬組成物

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2022538564A JPWO2022018875A1 (cg-RX-API-DMAC7.html) 2020-07-22 2020-07-22
PCT/JP2020/028575 WO2022018875A1 (ja) 2020-07-22 2020-07-22 アリールアミド誘導体を含む細胞増殖性疾患の治療又は予防用医薬組成物
JP2022538564 2020-07-22
JP2021121960A JP7168734B2 (ja) 2020-07-22 2021-07-26 アリールアミド誘導体を含む細胞増殖性疾患の治療又は予防用医薬組成物

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2021121960A Division JP7168734B2 (ja) 2020-07-22 2021-07-26 アリールアミド誘導体を含む細胞増殖性疾患の治療又は予防用医薬組成物

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2026044825A Division JP2026102816A (ja) 2020-07-22 2026-03-18 アリールアミド誘導体を含む細胞増殖性疾患の治療又は予防用医薬組成物

Publications (2)

Publication Number Publication Date
JP2023011759A JP2023011759A (ja) 2023-01-24
JP2023011759A5 true JP2023011759A5 (cg-RX-API-DMAC7.html) 2024-08-07

Family

ID=79729374

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2022538564A Pending JPWO2022018875A1 (cg-RX-API-DMAC7.html) 2020-07-22 2020-07-22
JP2021121960A Active JP7168734B2 (ja) 2020-07-22 2021-07-26 アリールアミド誘導体を含む細胞増殖性疾患の治療又は予防用医薬組成物
JP2022172687A Ceased JP2023011759A (ja) 2020-07-22 2022-10-27 アリールアミド誘導体を含む細胞増殖性疾患の治療又は予防用医薬組成物
JP2026044825A Pending JP2026102816A (ja) 2020-07-22 2026-03-18 アリールアミド誘導体を含む細胞増殖性疾患の治療又は予防用医薬組成物

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2022538564A Pending JPWO2022018875A1 (cg-RX-API-DMAC7.html) 2020-07-22 2020-07-22
JP2021121960A Active JP7168734B2 (ja) 2020-07-22 2021-07-26 アリールアミド誘導体を含む細胞増殖性疾患の治療又は予防用医薬組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2026044825A Pending JP2026102816A (ja) 2020-07-22 2026-03-18 アリールアミド誘導体を含む細胞増殖性疾患の治療又は予防用医薬組成物

Country Status (3)

Country Link
JP (4) JPWO2022018875A1 (cg-RX-API-DMAC7.html)
KR (2) KR102550455B1 (cg-RX-API-DMAC7.html)
WO (1) WO2022018875A1 (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115151533B (zh) 2020-01-10 2025-08-08 医疗免疫工程公司 Mek抑制剂及其治疗用途
AU2022312992A1 (en) * 2021-07-21 2024-02-29 Chugai Seiyaku Kabushiki Kaisha Method for producing arylamide derivative
WO2023204259A1 (ja) * 2022-04-20 2023-10-26 中外製薬株式会社 がんの治療又は予防用医薬
EP4551558A2 (en) * 2022-07-08 2025-05-14 Nested Therapeutics, Inc. Mitogen-activated protein kinase (mek) inhibitors
JP2026522033A (ja) * 2023-07-06 2026-07-03 華健未来(成都)科技股▲フン▼有限公司 芳香族アミド誘導体およびその使用
WO2025063275A1 (ja) * 2023-09-21 2025-03-27 中外製薬株式会社 アリールアミド誘導体の製造方法
AU2024417154A1 (en) * 2024-01-01 2026-08-13 Huajian Future (Chengdu) Technology Co., Ltd. Aromatic hydrazide derivative and medical use thereof
WO2026098657A1 (zh) * 2024-11-08 2026-05-15 先声再明医药股份有限公司 作为mek抑制剂的杂环化合物

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4931419B2 (ja) * 2003-09-19 2012-05-16 中外製薬株式会社 新規4−フェニルアミノ−ベンズアルドオキシム誘導体並びにそのmek阻害剤としての使用
KR101190912B1 (ko) * 2003-11-19 2012-10-12 어레이 바이오파마 인크. Mek의 헤테로시클릭 억제제 및 그의 사용 방법
MY144232A (en) * 2004-07-26 2011-08-15 Chugai Pharmaceutical Co Ltd 5-substituted-2-phenylamino benzamides as mek inhibitors
AR059339A1 (es) 2006-02-09 2008-03-26 Chugai Pharmaceutical Co Ltd Derivados de la cumarina para trastornos proliferativos de celulas, composicion farmaceutica y agente terapeutico que los contiene
WO2012020742A1 (ja) * 2010-08-10 2012-02-16 塩野義製薬株式会社 新規複素環誘導体およびそれらを含有する医薬組成物
US20130123255A1 (en) * 2011-11-10 2013-05-16 Chugai Seiyaku Kabushiki Kaisha Combination of a pi3k inhibitor and a mek inhibitor
JP2016034900A (ja) * 2012-11-26 2016-03-17 中外製薬株式会社 5−置換−2−フェニルアミノ−ベンズアミド類の製造方法
CN109988105A (zh) * 2014-01-27 2019-07-09 天津滨江药物研发有限公司 作为蛋白激酶抑制剂的氮杂环类化合物及其制备方法
CN105384738B (zh) * 2014-08-21 2017-08-29 上海科州药物研发有限公司 作为蛋白激酶抑制剂的杂环类化合物及其制备方法和用途
AR121078A1 (es) * 2020-01-22 2022-04-13 Chugai Pharmaceutical Co Ltd Derivados de arilamida con actividad antitumoral
KR20230122174A (ko) * 2020-07-22 2023-08-22 추가이 세이야쿠 가부시키가이샤 아릴 아마이드 유도체를 포함하는 조성물

Similar Documents

Publication Publication Date Title
JP2022068302A5 (cg-RX-API-DMAC7.html)
JP2024023385A5 (cg-RX-API-DMAC7.html)
JP2022028828A5 (cg-RX-API-DMAC7.html)
JP2022025124A5 (cg-RX-API-DMAC7.html)
JP2021185136A5 (cg-RX-API-DMAC7.html)
JP2021169491A5 (cg-RX-API-DMAC7.html)
JP2024059739A5 (cg-RX-API-DMAC7.html)
JP2023022224A5 (cg-RX-API-DMAC7.html)
JP2023116721A5 (cg-RX-API-DMAC7.html)
JP2024016014A5 (cg-RX-API-DMAC7.html)
JP2021038271A5 (cg-RX-API-DMAC7.html)
JP2022060295A5 (cg-RX-API-DMAC7.html)
JP2025506484A5 (cg-RX-API-DMAC7.html)
JP2023100643A5 (cg-RX-API-DMAC7.html)
JP2020171301A5 (cg-RX-API-DMAC7.html)
JP2020120660A5 (cg-RX-API-DMAC7.html)
JP2024112817A5 (cg-RX-API-DMAC7.html)
JP2025084837A5 (cg-RX-API-DMAC7.html)
JP2022537813A5 (cg-RX-API-DMAC7.html)
JP2023085551A5 (cg-RX-API-DMAC7.html)
JP2024534771A5 (cg-RX-API-DMAC7.html)
JP2020141705A5 (cg-RX-API-DMAC7.html)
JP2022022379A5 (cg-RX-API-DMAC7.html)
JP2024063214A5 (cg-RX-API-DMAC7.html)
JP2022122912A5 (cg-RX-API-DMAC7.html)